Development of a double-layer microfluidic chip with flow medium for chemotherapy resistance analysis of lung cancer.

Qiang Meng,Zhongzhou He,Lichuan Zhang,Long Zhao,Encheng Li,Qianqian Zhang,Xiaolin Zhang,Dongxia Yang,Lijuan Zou,Zhancheng Gao,Qi Wang
DOI: https://doi.org/10.1002/elps.201100086
2011-01-01
Electrophoresis
Abstract:Integration and miniaturization are main advantages of microchip-based systems. Vertical integration of the multiple operations within a multiple-layer chip is expected to satisfy the urgent demand for high-throughput and large-scale applications. This study aimed at establishing a double-layer chip to integrate the operations including the cell culture, the identification of the protein and the detection of the cell viability onto a platform systematically and supplied with flow fresh medium continuously via a syringe pump to mimic the microenvironment in vivo. With this device, human non-small cell lung cancer cell line (SPCA-1) was cultured well; the expression and the activity of multidrug resistance-associated protein (MRP1) were detected by immunofluorescence assay for the cells pretreated with or without MK-571, a known inhibitor of MRP1; apoptosis percentages were assayed for the cells after being treated by the anticancer drug etoposide (VP-16). The results demonstrated that the function of the MRP1 was inhibited by MK-571, and the percentage of apoptotic for the cells pretreated with MK-571 was higher than that of the control (38.2 +/- 2.5% versus 12.3 +/- 0.85%, p<0.005). All these indicated that the new device could provide a suitable condition for cell culture and functional analysis in biomedical research, and MK-571 is an effective inhibitor of MRP1 associated with the viability of SPCA-1 cell line treated by VP-16.
What problem does this paper attempt to address?